Accuvest Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Accuvest Global Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,602	Closed	-$1.88M	–	130
2023 Q2	$1.88M	Buy	3,602 +325	+10%	+$175K	0.96%	31
2023 Q1	$1.89M	Sell	3,277 -4,777	-59%	-$2.69M	0.85%	27
2022 Q4	$4.43M	Buy	8,054 +3,826	+90%	+$2.03M	1.47%	20
2022 Q3	$2.14M	Buy	4,228 +1,228	+41%	+$687K	1.47%	21
2022 Q2	$1.63M	Buy	+3,000	New	+$1.65M	1.05%	29
2022 Q1	–	Sell	-479	Closed	-$320K	–	121
2021 Q4	$320K	Sell	479 -16	-3%	-$9.99K	0.14%	88
2021 Q3	$287K	Sell	495 -79	-14%	-$43.4K	0.14%	101
2021 Q2	$290K	Buy	+574	New	+$271K	0.15%	87

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Accuvest Global Advisors's TMO Position: Q3 2023 in Review

Accuvest Global Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 3,602 shares — an estimated $1.88M sold.

Accuvest Global Advisors first reported a position in TMO in Q2 2021 and held it in 8 quarters. The position peaked at $4.43M in Q4 2022. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Accuvest Global Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
Accuvest Global Advisors sold 3,602 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.88M.
Accuvest Global Advisors first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 8 quarters.
Accuvest Global Advisors's Thermo Fisher Scientific position peaked at $4.43M in Q4 2022.
2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Accuvest Global Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.